Clinical Trial Update: PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease [Phase 4]

View source ↗

Summary

Clinical Trial Update: PATHFINDER is a Phase 4 study evaluating optimal first-line treatment strategies for moderate-to-severely active ileal-dominant Crohn's d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: University of Calgary | Conditions: Crohn Disease | Phase 4 | Status: RECRUITING